A detailed history of Commodore Capital LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Commodore Capital LP holds 1,911,433 shares of PHVS stock, worth $37.4 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
1,911,433
Previous 1,810,175 5.59%
Holding current value
$37.4 Million
Previous $34 Million 4.02%
% of portfolio
3.01%
Previous 3.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.73 - $21.4 $1.59 Million - $2.17 Million
101,258 Added 5.59%
1,911,433 $35.4 Million
Q2 2024

Aug 14, 2024

BUY
$15.67 - $24.59 $1.33 Million - $2.09 Million
85,175 Added 4.94%
1,810,175 $34 Million
Q1 2024

May 15, 2024

BUY
$21.26 - $32.07 $19.7 Million - $29.7 Million
925,000 Added 115.63%
1,725,000 $39.9 Million
Q4 2023

Feb 14, 2024

BUY
$15.2 - $28.05 $12.2 Million - $22.4 Million
800,000 New
800,000 $22.4 Million

Others Institutions Holding PHVS

About Pharvaris N.V.


  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $661M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.